Small scale bioreactors are automated equipment used for growth of microbial and cell cultures on a small scale in biopharmaceutical, biotechnology and pharmaceutical industries. They are beneficial for various applications including process and method development, quality control testing, pilot plant studies and clinical/pre-clinical scale up.
The global small scale bioreactors market is estimated to be valued at US$ 253.14 Billion in 2024 and is expected to exhibit a CAGR of 15% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the small scale bioreactors market are Conair, Helen of Troy, Cezanne, Kizure, InfinitiPro, BaBylissPRO, Hot Tools, Remington, HSI Professional, Bio Ionic, Russell Hobbs, Xtava, Herstyler, Bed Head, John Frieda, Tresemme, Revlon, Paul Mitchell, CHI, Babyliss.
The growing R&D investments as well as increased acceptance of disposable bioreactors by pharmaceutical firms are expected to drive Small Scale Bioreactors Market Demand over the forecast period. In addition, many biotech companies are expanding their presence across various geographical regions especially in Asia Pacific and Europe which is anticipated to provide opportunities for players in the small scale bioreactors market. Market key trends Use of single-use bioreactors is a key trend witnessed in the small scale bioreactors market. Single-use bioreactors are pre-sterilized and disposable bags or vessels used for cell culture processes. They eliminate the need for sterilization and validation of the equipment after each run thus reducing operational costs. Their use has increased significantly over the past few years as they minimize the risk of cross-contamination. This trend is expected to continue driving market growth over the forecast period.
Porter’s Analysis Threat of new entrants: The barriers to entry are moderately high as setting up manufacturing and distribution setup would require significant capital investments. Bargaining power of buyers: The buyers have moderate to low bargaining power as there are numerous players in the market offering substitutable products. Bargaining power of suppliers: The suppliers have moderate bargaining power as raw materials used in manufacturing bioreactors are commoditized and available from numerous suppliers globally. Threat of new substitutes: The threat is low as bioreactors currently have no close substitute for carrying out biological experiments. Competitive rivalry: The competition is high among the existing players to gain higher market share through continuous innovations, pricing strategies and targeted marketing. Geographical Regions North America currently holds the major share of the global Small Scale Bioreactors Market Companies in terms of value owing to presence of numerous biotech companies and research organizations actively involved in R&D activities. Asia Pacific is expected to witness the highest growth over the forecast period attributed to increasing outsourcing of clinical research to China and India, rising pharmaceutical production, and growing biotech sector in countries like China, India and South Korea.
Select the language you're most comfortable with-
About Author-
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Known for her strong SEO background, she skillfully blends SEO strategies with insightful content. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)
